Cancer survivor Angie Blankenship has learned to manage the challenges of healing with support from her family, friends and the WVU Cancer Institute. Now, she’s showing appreciation and paying it forward by donating to the Bob Huggins Fish Fry, which benefits the Norma Mae Huggins Endowment Fund and Remember the Miners Scholarship Fund.
Whenever Larry Cole returns to Morgantown for cancer treatment, he and his wife, Becky, always get a warm welcome at Rosenbaum Family House.
Applications due March 2 for Summer Undergraduate Research Program
Dr. Kimberly Kelly, an Associate Professor in the School of Pharmacy, Pharmaceutical Systems & Policy and a member of the WVU Cancer Institute Research Program, has been named an Associate Editor of the Journal of the American Pharmacists Association.
The WVU Cancer Institute has enrolled two of the first three patients in a national clinical trial for a novel breast cancer vaccine.
The WV Lung Cancer Project (WVLCP) was invited to present a poster at the 2019 National Lung Cancer Roundtable Meeting in Washington, DC on December 9-10th. Representatives from WVU Cancer and the Patient Advocate Foundation, a partner organization, attended the conference with a record number of 300+ professionals from around the country. The WVLCP’s poster depicted the change in lung cancer screening infrastructure in WV since the project’s inception. At the start of 2016, there were only five lung cancer screening facilities in WV that could screen and bill most major insurances; today that number is 24. The WVLCP assisted 12 additional centers in becoming accredited through the American College of Radiology.
This year's pancake breakfast fundraiser benefitting the Comfort Fund at the WVU Cancer Institute Mary Babb Randolph Cancer Center (MBRCC) had a record attendance of 159 people and raised over $1,300.
According to a new study by West Virginia University researcher Nancy Lan Guo, the microscopic toner nanoparticles that waft from laser printers may change our genetic and metabolic profiles in ways that make disease more likely. Her findings appear in the International Journal of Molecular Sciences.
Hannah Hazard-Jenkins, M.D., associate chair of surgery for cancer services, has been named interim director of the WVU Cancer Institute, effective January 2020.
